Effects of intrathecal MSC-derived neural progenitors (MSC-NP) treatment on biomarker levels in the CSF in patients with progressive multiple sclerosis

Staff: 
Saud A. Sadiq, MD, FAAN
Violaine K. Harris, PhD
John Tuddenham, BA